News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
179 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21637)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3636)
June (2415)
July (2092)
August (1945)
Day
2 (2)
3 (145)
4 (188)
5 (190)
6 (124)
7 (71)
10 (179)
11 (91)
12 (168)
13 (122)
14 (57)
17 (142)
18 (120)
19 (151)
20 (179)
21 (55)
24 (93)
25 (131)
26 (123)
27 (118)
28 (134)
31 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Press Releases
Currax Secures Reliable and Consistent Supply of CONTRAVE®/MYSIMBA with FDA Approval for Second Manufacturing Site
March 20, 2025
·
8 min read
Press Releases
ImmunoGenesis to Present in Innovation Track of the 2025 NeauxCancer Oncology Conference in New Orleans
March 20, 2025
·
3 min read
Press Releases
BIOQuébec Opens Up to Medtech Companies and Expands Its Representation
March 20, 2025
·
1 min read
Press Releases
Adaptimmune Provides Q4 and Full Year 2024 Business Update
TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals achieved Lete-cel on track to initiate rolling BLA submission late 2025; approval anticipated 2026 Corporate restructure completed in February 2025 and implementing additional cost reduction for PRAME and CD70 programs At the end of 2024, Adaptimmune had Total Liquidity1 of $152 million Evaluating all strategic options to maximize shareholder value
March 20, 2025
·
7 min read
Press Releases
BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025
March 20, 2025
·
4 min read
Press Releases
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
March 20, 2025
·
5 min read
Press Releases
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
March 20, 2025
·
8 min read
Press Releases
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
March 20, 2025
·
10 min read
Press Releases
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
March 20, 2025
·
11 min read
Press Releases
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
March 20, 2025
·
12 min read
Previous
11 of 18
Next
